SNPsig® SARS-CoV-2 (N501Y)

• For the detection of the SARS-CoV-2 variants with the N501Y mutation (UK, South Africa and Brazil)

Our SNPsig kits use our own proprietary genotyping method to enable the identification of SARS-CoV-2 variants of concern. These products can be used on any real-time PCR machine using familiar protocols, whilst resulting in exceptional genotyping data.

Positive control templates for wild-type and variants are supplied in every kit to make data interpretation simple.

Our SNPsig technology provides an alternative to sequencing as well as S gene target failure (SGTF) that enables scientists to analyse and monitor these specific genomic mutations.  Our kits can provide a pivotal role in screening for SARS-CoV-2 variants for the purpose of genomic surveillance and studies.

• Rapid detection of specific detection profiles
• High priming efficiency
• Sensitive to < 100 copies of target
• Positive copy number standard curve for quantification
• Accurate controls to confirm findings
• 96 reactions